Anti-EBV-CA IgM, anti-EBV-EA(D) IgG, and anti-EBV-EA(D) IgM antibodies were more prevalent in SLE patients than in controls (p<0.001, p<0.001, and p=0.008, respectively). This evidence concerns the gene CD40LG and systemic lupus erythematosus.